Research output per year
Research output per year
Fingerprint
Dive into the research topics where Wenli Dong is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Implications of omitting sentinel lymph node biopsy on adjuvant decision making for patients with small breast cancers
Wanis, K. N., Mitchell, M. P., Giordano, S. H., Litton, J. K., Shaitelman, S. F., Tamirisa, N., Bedrosian, I., Dong, W., Shen, Y., Hunt, K. K., Singh, P., Sun, S. X., Caudle, A. S., Kuerer, H. M., Meric-Bernstam, F., Hwang, R. F. & Adesoye, T., Jun 1 2025, In: Cancer. 131, 11, e35910.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Neoadjuvant HER2-targeted regimens with or without anthracyclines for HER2-positive inflammatory breast cancer: a multicenter retrospective study
Iwase, T., Sridhar, N., Kai, M., Dong, W., Shen, Y., Krishnamurthy, S., Lucci, A., Le-Petross, H. T. C., Nasrazadani, A., Saleem, S., Layman, R. M., Valero, V., Tripathy, D., Woodward, W. A., Cheng, Y. C., Nakhlis, F., Bellon, J. R., Lynce, F. & Ueno, N. T., Nov 2025, In: Breast Cancer Research and Treatment. 214, 1, p. 69-77 9 p.Research output: Contribution to journal › Article › peer-review
-
Outcomes of elderly patients with relapsed refractory multiple myeloma (RRMM) treated with teclistamab: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium
Pasvolsky, O., Dima, D., Feng, L., Dong, W., Richards, T., Davis, J. A., Afrough, A., Vazquez-Martinez, M., Sannareddy, A., Goel, U., Banerjee, R., Khouri, J., Cervoni, F., Gaballa, M. R., Lieberman-Cribbin, A., Rana, M. S., Julian, K., Ferreri, C. J., Shune, L. & DeJarnette, S. & 31 others, , Dec 2025, In: Blood cancer journal. 15, 1, 92.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Predicting pathologic ≥N2 disease in women with breast cancer
Wanis, K. N., Dong, W., Shen, Y., Meric-Bernstam, F., Adesoye, T., Kuerer, H. M., Caudle, A. S., Tamirisa, N., DeSnyder, S. M., Sun, S. X., Bedrosian, I., Singh, P., Cox, S. E., Hunt, K. K. & Hwang, R. F., Dec 2025, In: npj Breast Cancer. 11, 1, 46.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Reassessing estrogen receptor expression thresholds for breast cancer prognosis in HER2-negative patients using shape restricted modeling
Dong, W., Fujii, T., Ning, J., Iwase, T., Qin, J., Ueno, N. T. & Shen, Y., Dec 2025, In: Scientific reports. 15, 1, 5590.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations